Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma
John W. Figg, Caitland Love, Illeana West, Dan Jin, Mia Engelbart, Dorothy Ware, Rachael Bessey, Catherine T. Flores · 2026
Read Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma by John W. Figg, Caitland Love, Illeana West, Dan Jin, Mia Engelbart, Dorothy Ware, Rachael Bessey, Catherine T. Flores (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13296615.txt.
Description
John W. Figg and colleagues review, in 2026, suppressor cells that blunt immune attack in glioblastoma, the most aggressive common brain tumour. These immature myeloid cells gather in the tumour and shield it, one reason immunotherapy struggles there.
The review gathers clinical and large-scale molecular evidence placing the cells at the centre of suppression, then details the chemical signals and receptors that draw them in and keep them alive. Treatments that remove, block or reprogramme the cells, now in trials, get close attention. The authors aim to guide neuro-oncology teams targeting this shield.
Catalog record
| CREATOR | John W. Figg, Caitland Love, Illeana West, Dan Jin, Mia Engelbart, Dorothy Ware, Rachael Bessey, Catherine T. Flores |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29737 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |